MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 99 filers reported holding MIRUM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,175,038 | +465.2% | 163,767 | +362.7% | 0.00% | – |
| Q2 2023 | $915,618 | -6.1% | 35,393 | -12.8% | 0.00% | – |
| Q1 2023 | $974,636 | +22.1% | 40,576 | -0.9% | 0.00% | – |
| Q4 2022 | $798,448 | +17.1% | 40,946 | +26.1% | 0.00% | – |
| Q3 2022 | $682,000 | +7.2% | 32,481 | -0.7% | 0.00% | – |
| Q2 2022 | $636,000 | -5.8% | 32,702 | +6.6% | 0.00% | – |
| Q1 2022 | $675,000 | -11.4% | 30,691 | -35.7% | 0.00% | – |
| Q4 2021 | $762,000 | -3.1% | 47,757 | +21.1% | 0.00% | – |
| Q3 2021 | $786,000 | -3.9% | 39,438 | -16.7% | 0.00% | – |
| Q2 2021 | $818,000 | -9.2% | 47,328 | +4.1% | 0.00% | – |
| Q1 2021 | $901,000 | +14.8% | 45,470 | +1.1% | 0.00% | – |
| Q4 2020 | $785,000 | +13.6% | 44,965 | +25.5% | 0.00% | – |
| Q3 2020 | $691,000 | – | 35,822 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,566,912 | $62,278,000 | 4.80% |
| RiverVest Venture Management LLC | 1,921,118 | $33,543,000 | 3.68% |
| Burrage Capital Management LLC | 161,628 | $2,822,000 | 2.15% |
| AIGH Capital Management LLC | 274,583 | $4,794,000 | 1.95% |
| NEA Management Company, LLC | 4,187,801 | $73,119,000 | 1.93% |
| Novo Holdings A/S | 2,445,147 | $42,692,000 | 1.83% |
| Sio Capital Management, LLC | 494,743 | $8,638,000 | 1.77% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,448,912 | $60,218,000 | 1.19% |
| Rock Springs Capital Management LP | 1,496,525 | $26,129,000 | 0.55% |
| Prosight Management, LP | 60,250 | $1,052,000 | 0.49% |